data-analytics-with-python-classroom-1a8e1c-emoji-mapping-emoji_mapping data-analytics-with-python-classroom-1a8e1c-emoji-mapping-emoji_mapping Public data-analytics-with-python-classroom-1a8e1c-emoji ...
Corsera Health Inc. has filed a clinical trial notification (CTN) seeking to initiate a phase I trial of COR-1004 in New Zealand. COR-1004 is a novel investigational subcutaneously administered siRNA ...
BOSTON--(BUSINESS WIRE)--Corsera Health, Inc., leading the future of cardiovascular health through prediction and prevention, today announced the filing of a clinical trial notification (CTN) to ...
Advancing a once-annual preventive RNAi medicine designed to reduce the two key drivers of cardiovascular disease: LDL-C and blood pressure Filed application for COR-1004, a novel siRNA targeting ...
Salesloft said a breach of its GitHub account in March allowed hackers to steal authentication tokens that were later used in a mass-hack targeting several of its Big Tech customers. Citing an ...
Corsera Health, Inc. announced its launch today with a mission to extend healthspan through cardiovascular disease prediction and prevention. The company will shape the future of cardiovascular health ...
– Late-breaking presentation at ESC Congress 2025 confirms that early, persistent lowering of LDL-C and blood pressure leads to improved cardiovascular health outcomes – – Raised over $50 million to ...
Industry giants Clive Meanwell, M.D., and John Maraganore, Ph.D., have unveiled Corsera Health, a new biotech aiming to disrupt the cardiovascular landscape with a once-annual preventive heart disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback